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Abstract
Objectives: We aimed to determine the feasibility of an online randomised controlled trial (RCT) of the Men’s Safer Sex
website, measuring condom use and sexually transmitted infection (STI).
Methods: For this study 159 men aged 16 with female sexual partners and recent condomless sex or suspected STI were
recruited from three UK sexual health clinics. Participants were randomised to the intervention website plus usual clinic care
(n¼ 84), or usual clinic care only (n¼ 75). Online outcome data were solicited at 3, 6, and 12 months.
Results: Men were enrolled via tablet computers in clinic waiting rooms. Software errors and clinic Wi-Fi access presented
significant challenges, and online questionnaire response rates were poor (36% at 3 months with a £10 voucher; 50% at
12 months with £30). Clinical records (for STI diagnoses) were located for 94% of participants. Some 37% of the intervention
group did not see the intervention website (n¼ 31/84), and (as expected) there was no detectable difference in condomless
sex with female partners (IRR¼ 1.01, 95% CI 0.52 to 1.96). New acute STI diagnoses were recorded for 8.8% (7/80) of the
intervention group, and 13.0% (9/69) of the control group over 12 months (IRR¼ 0.75, 95% CI 0.29 to 1.90).
Conclusion: It is likely to be feasible to conduct a future large-scale RCT to assess the impact of an online intervention using
clinic STI diagnoses as a primary outcome. However, practical and technical challenges need to be addressed before the
potential of digital media interventions can be realised in sexual health settings.
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Introduction
Men’s sexual health
Sexually transmitted infections (STI) are a major public
health problem, with high social and economic costs.
The majority of genital warts, herpes and chlamydia
occurs in opposite sex partnerships, with other infec-
tions (syphilis, gonorrhoea and HIV) particularly
aﬀecting men who have sex with men.1 Condoms are
eﬀective for prevention of STI; however, there are
many barriers to successful use, for example decrease
in sensation, interruption of sex, incorrect size or ﬁt, use
of alcohol/recreational drugs, anxiety aﬀecting sexual
performance and stigma associated with carrying con-
doms.2,3 Condoms can be a barrier to intimacy and
trust,3 and use is often lower in established
relationships.4
Prevention eﬀorts are needed to target the obstacles
to condom use that men face.2 While there are a variety
of health promotion interventions aimed at improving
sexual health for men who have sex with men (MSM),
there are fewer interventions speciﬁcally for adult men
who have sex with women (MSW),5,6 despite the fact
that MSW report more inconsistent condom use than
MSM.7 Men are less likely than women to visit health
professionals and generally have shorter clinic appoint-
ments,8,9 so may be less likely to be oﬀered health pro-
motional advice or risk reduction counselling in routine
appointments. Men may also be reluctant to discuss
their sexual health with health professionals, partners
or friends.10 An online intervention may therefore oﬀer
an alternative avenue to reach men.11
Digital interventions for sexual health
There has been an explosion of interest in digital health
worldwide, since mobile phone and internet interven-
tions can facilitate access to self-care as well as relieving
pressure on over-stretched or scarce health services.12
However, the pace of innovation is outstripping the
capacity to evaluate digital interventions rigorously.13
Interactive digital interventions (IDIs) are computer-
based programs that provide information and one or
more of decision support, behaviour-change support or
emotional support for health issues, through provision
of personally relevant tailored material.11 IDIs are suit-
able for sexual health promotion because access can be
private, anonymous and self-paced.14 Interventions can
be targeted for speciﬁc groups (e.g. by age, gender or
sexuality), and content can be tailored for individuals.15
IDIs can be costly to develop, but oﬀer the advantages
of intervention content ﬁdelity16 and the potential to
reach large audiences at relatively low dissemination
costs.17 IDIs can impact upon sexual behaviour (such
as condom use)11,18 as well as increasing knowledge,
self-eﬃcacy and safer sex intention.11,19 More evidence
is needed to establish eﬀects on biological outcomes
(STI) and cost-eﬀectiveness.
The Men’s Safer Sex website is an IDI designed to
increase condom use and reduce STI. The website
addresses men’s barriers to condom use, providing tai-
lored advice for individuals.20,21
National Health Service sexual health clinics
Sexual health clinic provision varies across the UK.17
National Health Service (NHS) provision is free and
conﬁdential, and services can be accessed using a
pseudonym if wanted, since proof of identity is not
required. Waiting times can be long, especially for
drop-in services in areas of high demand. Clinics
often have electronic medical records that are not inte-
grated with other hospital or family doctor records, and
facilities such as patient access to Wi-Fi are not rou-
tinely available. Since it is usual to wait some period of
time before seeing a sexual health clinician, we chose to
oﬀer the Men’s Safer Sex website in sexual health clinic
waiting rooms, to take advantage of a potential ‘teach-
able moment’.13
Digital interventions can be particularly appropriate
for sexual health,17 and online trials have the potential
to be an eﬃcient and cost-eﬀective way to conduct
research.16 However, it can be diﬃcult to recruit
people to trials in clinical settings, and it can be diﬃcult
to retain participants in online trials.16 This feasibility
trial was designed to evaluate recruitment and retention
rates and methods of sexual health outcome measure-
ment, to add to evidence about how to conduct rigor-
ous eHealth research in healthcare settings.
Aim
The aim of this study was to establish the feasibility and
optimal design of a full-scale randomised controlled
trial (RCT) to evaluate the eﬀect of the Men’s Safer
Sex website on condom use and STI acquisition
among men attending sexual health clinics.
Research questions
. Is it feasible to recruit MSW to an online trial
(in sexual health clinic settings)?
. What proportion of men can be retained in an online
trial at 3, 6 and 12 months?
. What proportion of clinic records can be located
(for STI diagnoses over 12 months)?
. Is it feasible to collect data on the main outcomes of
interest at 3 and 12 months (condom use and STI
acquisition)?
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. What proportion of the intervention group will
access the intervention website?
Methods
Design
This study was a feasibility RCT,22 with ethical com-
mittee approval from City and East NHS Research
Ethics Committee (reference number 13 LO 1801).
Participants and setting
Participants were recruited from three busy English
sexual health clinics, two in central London and one
in the West Midlands.23 These clinics served a diverse
range of patients in terms of age, socio-economic
status, ethnicity and sexuality.
Inclusion criteria
Inclusion criteria were: men aged 16 years and
over (with no upper age limit); able to read English;
with access to the internet; and at high risk of future
STI (i.e. two or more sexual partners in the past
year and some non-condom use in the last 3 months;
or symptoms of acute STI; or seeking treatment for
an STI); and for whom at least half of their sexual
partners are female. HIV-positive men and men with
hepatitis B or C were excluded, since patients with these
diagnoses are likely to receive health promotion in the
course of routine clinical care. Men who have had
sexual experience only ever with males, predominately
with males, or no sexual experience at all were also
excluded.
Intervention
The Men’s Safer Sex website content and design was
based on evidence from the sexual health literature,
theories of behaviour change, qualitative interviews
with men in sexual health clinics and discussions with
clinical and academic experts in sexual health and digi-
tal technologies.20 The development process was itera-
tive, with a high level of user involvement.20 The
website addresses men’s barriers to condom use, par-
ticularly condom use skills, impact upon pleasure and
judgement about potential risk of STI. The website
content incorporates behaviour-change techniques,
and provides tailored feedback for individual users to
address their barriers to condom use (See Appendix 1,
Men’s Safer Sex website screenshots). The website is
designed to be delivered initially in clinic, to make use
of the time when patients are waiting to be seen, but
also provides online access after patients have left the
clinic. The intervention website content and design are
reported in detail elsewhere.20,21 The website is avail-
able at www.menss.co.uk.
Procedures
Participants were screened for eligibility, gave informed
consent and completed baseline questionnaires using a
tablet computer positioned in the waiting room or a
side room of the sexual health clinics. The study was
advertised in leaﬂets and on posters, and research and
clinic staﬀ also directed participants to the tablet com-
puter. Enrolment was self-directed, with staﬀ available
to help with technical problems only. Eligibility was
checked with a short set of screening questions online,
and eligible participants provided informed consent
online. Baseline data were collected online, and then
participants received a message informing them of
whether they had been randomly allocated to the con-
trol group or the intervention group. Those allocated to
the intervention group were asked to engage with the
MenSS website for as long as they wished (usually until
they were called in to see health professionals). They
also had access to the website after leaving the clinic, by
logging in.
At 3, 6, and 12 months after their initial clinic visit,
participants were invited via email to complete an
online follow-up questionnaire. If they did not initially
complete questionnaires, they received three further
email prompts at 1-week intervals, as well as two text
messages to their mobile phone. If participants still did
not respond, a researcher telephoned them 1 week after
the ﬁnal email and text message. Self-reported STI
diagnoses were collected at all time points, and clinical
diagnoses were collected at 12 months by recording
diagnoses or suspected diagnoses noted in clinic records
at the sexual health clinics that participants were
recruited from.
Outcomes
We measured response rates for the online question-
naire at 3, 6 and 12 months, and proportion of clinic
records which could be located using details given by
participants. For sexual health outcomes, we adapted
the Sexunzipped online sexual health questionnaire,24
selecting items for inclusion based on a literature
search for established measures and consultation with
experts. Interviews were conducted with men in sexual
health clinics (N¼ 11) to gain feedback on successive
versions of the outcome questionnaire, and we modiﬁed
the structure and content of the outcome questionnaire
based on men’s feedback.22
In the light of evidence that measurement alone may
prompt behaviour change,25,26 a limited number of
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outcomes was measured at baseline (condom use and
hypothesised main mediators, and self-reported STI
diagnoses), and a full range of outcomes was assessed
at 3, 6 and 12 months (see Table 1 and Appendix 2).
Important reasons for condomless sex are being in a
regular relationship, and not relying on condoms for
contraception, so we asked about these factors to
allow a more nuanced interpretation of ‘condomless
sex’. We asked about motivation, intention, beliefs
about pleasure and non-condom use at baseline,
since we felt these to be the strongest predictors of
condom use. All assessments had a recall period of
the previous three months.
Sexual health outcome measures
Condom use. The objective of the study was to pro-
mote condom use for penetrative sex,22 and so the main
sexual health outcome of interest was the number of
episodes of condomless vaginal or anal sex with
female partner/s over the previous 3 months, assessed
at the 3-month follow-up. We anticipated that the main
opportunity for engagement with intervention website
would be at the initial clinic visit, and that any change
in condom use behaviour would occur over the subse-
quent 3 months.
Sexual partners. Participants were asked to report
the number of sexual partners over the last 3 months
(both female and male). The number of partners with
whom participants had condomless sex over the previ-
ous 3 months was also assessed: female (vaginal and
anal sex) and male (anal sex).
Contraception use and pregnancy. Participants were
asked which types of contraception (if any) female part-
ners were using. Participants were asked whether a
female partner had been pregnant in the last 3
months, and the outcome of that pregnancy if known.
STI diagnoses. Participants were asked to report STI
diagnoses over the past 3 months at every follow-up
point. Participants were also asked whether they had
received treatment due to a partner being diagnosed
with an STI. In order to assess laboratory diagnoses,
all STI diagnoses recorded in sexual health clinic rec-
ords over the 12-month study period (at the participat-
ing sites) were collected at the end of the study.
Engagement with the intervention (patterns of website
use). Customised DrupalTM web analytics software was
used to record website usage (times the website was
visited, pages visited), to assess engagement with the
Men’s Safer Sex intervention.
Adverse effects. Adverse impacts on sexual health
outcomes were recorded at 3, 6 and 12 months.
Beyond noting any deterioration in outcome measures,
participants were also asked to report whether they had
experienced any adverse impacts as a result of the
study, recording this in a free text box on each of the
follow-up questionnaires.
Hypothesised mediators of condom use. We measured
hypothesised mediators of condom use behaviour
change which were speciﬁcally targeted within the
Table 1. Variables assessed at each time point.
Baseline measures
3, 6, and 12-month follow-up
assessments
Demographic details (age,
employment status,
ethnicity)
Sexual health outcomes
Number of sexual partners Number of sexual partners
Condom use  number of
episodes of condomless sex
Numbers of sex partners
(without condoms)
Condom use  number of
episodes of condomless sex
Numbers of sex partners
(without condoms)
Self-reported STI diagnoses Self-reported STI diagnoses
Contraception use and preg-
nancy in female partners
Contraception use and pregnancy
in female partners
Health-Related Quality of Life Health-Related Quality of Life
Health service use
Possible mediators of condom use
Motivation to use condoms Motivation to use condoms
Intentions to use condoms Intentions to use condoms
Beliefs about pleasure Beliefs about pleasure
Non-condom use due to
intoxication
Non-condom use due to
intoxication
Evaluation of condom use
Communication
Identity
Self-efficacy
Condom problems
Knowledge
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intervention, to explore the mechanisms by which
behaviour might have changed (see Appendix 2, out-
come questionnaire). Determinants of condom use were
identiﬁed using the theoretical frameworks of the
COM-B model27 and the PRIME theory of motiv-
ation.28 Mediators included condom use errors and
problems;29 knowledge of risk of STIs and condom
sizes; communication with partners;30 perceptions of
identity and condom use;28 beliefs about pleasure and
condom use;31 self-eﬃcacy;32 motivation; and condom-
less sex due to intoxication. Full details of all trial out-
come variables are described in the Men’s Safer Sex
RCT protocol.22 Online questions were compulsory,
so completeness of data for participants who submitted
outcome questionnaires was excellent.
Randomisation
Once participants had been checked for eligibility,
given informed consent and submitted baseline data,
they were randomly allocated 1:1 using an automated
computer algorithm to either the intervention or con-
trol group. This allocation was unalterable.
Blinding
It was not possible to blind participants to their alloca-
tion, as those in the control condition received ‘usual
care’, with no access to an intervention website.
Research staﬀ were blind to allocation condition, as allo-
cation occurred automatically on the tablet computer;
however, allocation group could sometimes be inferred
by the length of time that participants spent on the tablet
computer. Data were analysed by statisticians who were
blinded to group identiﬁcation during analysis.
Statistical methods
The treatment eﬀect at follow-up was estimated using
generalised linear models with a loge link and Poisson
error. The loge of the baseline values were included in
each model as explanatory variables to account for
baseline diﬀerences. Standard errors were estimated
using variance components to account for over disper-
sion in the models. Incidence rate ratios (IRRs) com-
paring the control versus intervention groups were
estimated from these models along with their 95% con-
ﬁdence intervals and p-values.
Results
Recruitment
Recruitment into the trial was successful: the target
sample size was achieved in just over 2 months
(28 April 2014 to 7 July 2014), with the greatest rates
of recruitment on days when a researcher was present
to remind staﬀ and patients about the study. Follow-up
data were collected between 28 July 2014 and 2 July
2015. Participant ﬂow is outlined in Figure 1. Due to
a technical error in the online recruitment software,
reasons for exclusion were only available for 20 partici-
pants out of 159. In total, 176 participants were rando-
mised. Of these, seven withdrew from the study, one
was a duplicate account, and nine were withdrawn
due to being later found to be ineligible (they had
been erroneously classed as eligible due to a technical
error in the eligibility screening questionnaire).
Of 159 participants, 57 (36%) responded to the 3-
month online questionnaire, which was the main out-
come point (see Figure 1). An increase in the incentive
from £10 (at 3 and 6 months), to £30 (at 12 months)
appeared to have a positive eﬀect on response rates: 79
out of 159 (50%) ﬁlled in the online questionnaire at 12
months. Data from clinic records on STIs and on
sexual health service use were available for 149/159
(93.7%) participants.
Participants
Characteristics of participants are shown in Table 2.
The mean age of participants is in line with data that
suggest people in the 2534 years age bracket are more
likely to attend for STI testing,33 and employment
status and ethnicity were comparable with the general
population.34
Website usage
Some 37% of participants in the intervention group
visited the Men’s Safer Sex website once (n¼ 31/84),
26% more than once (n¼ 22/84), and 37% did not
see the website at all (n¼ 31/84). Twenty-two (26%)
participants returned to the website after leaving the
clinic, with 59% of these participants logging into the
website twice in total (n¼ 13/22). The maximum
number of return visits was eight. Participants visited
a median number of 15 pages out of a total of 34 main
topic or activity pages. Several factors hampered men’s
access to the intervention website: technical problems
with clinic Wi-Fi stability, time taken with online
research procedures (registration, consent, baseline out-
come measurement), and being called in to appoint-
ments before accessing the intervention website.
Descriptive statistics
Distributions of outcomes for condom use, STI diag-
noses and potential mediators of behaviour change are
reported in Table 3 and Table 4.
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It can be seen that there was an apparent increase
in episodes of condomless sex reported by men in
both the intervention and control groups over the
3 months of follow-up from baseline (Table 3). The
median numbers of episodes of condomless sex
reported at 3 months were small (12 and 10 for the
control and intervention groups, respectively) and
attrition was large, so these results are subject to bias.
The median numbers of (condomless sex with)
male and female partners, and STI over 3 months
were very small (median 0 to 1). We present
these results descriptively without signiﬁcance
testing since the small numbers preclude meaningful
analyses.
Assessed for eligibility: 
unknown (software error) 
Excluded  (n = 16 of 20 screened) 
- Aged under 16 (n = 0 ) 
- >half partners male (n = 3) 
- No risky behaviour or suspected STI (n= 9) 
- No internet access (n= 4) 
- HIV or hepatitis (n= 2) 
– some participants met more than one 
exclusion criterion
Responded to 3 month online 
questionnaire (n = 23) 
Allocated to intervention (n = 99) 
Baseline data missing (n =12) 
Allocated to control group (n = 77) 
Baseline data missing (n= 3) 
Allocation 
Analysis 
3 month follow-up 
Randomised (N = 176) 
Enrolment 
12 month follow-up 
6 month follow-up 
Excluded from trial 
due to being ineligible    
(n = 9) 
Withdrew (n = 6) 
Duplicate account  
(n = 1) 
Withdrew from study 
(n = 1) 
Responded to 3 month online 
questionnaire (n = 34) 
Responded to 6 month online 
questionnaire (n = 35)  
Responded to 6 month online 
questionnaire (n = 23) 
Responded to 12 month online 
questionnaire (n = 43) 
STI data from clinic records n = 69 
Responded to 12 month online 
questionnaire (n = 36) 
STIdatafromclinic records n = 80
Figure 1. CONSORT diagram showing flow of participants.
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Table 4 shows the distribution of outcomes which
may be mediators of change (i.e. factors potentially
inﬂuencing condom use and STI acquisition).
We present these results descriptively without signiﬁ-
cance testing since the small numbers preclude mean-
ingful analyses.
Group comparisons for condomless sex and STI
The main aim of the feasibility study was to assess
response rates to follow-up outcome data, and the
study was not powered to assess diﬀerences between
groups. Measures of condomless sex with female part-
ners were similar in the intervention and control groups
at 3 months (IRR 1.01; 95% CI 0.52 to 1.96) (see Table
5). In total, 23 diagnoses of acute STI (one or more over
12 months) were recorded in the clinical notes of 15 trial
participants (seven non-speciﬁc urethritis; seven
Chlamydia trachomatis; three Neisseria gonorrhoea;
two epididymitis; two Molluscum contagiosum; and
two people were treated as chlamydia contacts). New
acute STI diagnoses were recorded for 8.8% (7/80) of
men in the intervention group, and 13.0% (9/69) in the
control group over the course of 12 months. There was
no statistically signiﬁcant diﬀerence between the groups
(IRR 0.75; 95% CI 0.29 to 1.90).
Discussion
In this study we explored the feasibility of a full-scale
online RCT (in sexual health clinic settings) of the
Men’s Safer Sex website for MSW. Recruitment into
the trial was successful, and retrieval of clinic records
for clinical STI diagnoses was 94%. A larger incentive
(£30 voucher) oﬀered at 12 months and resolution of
technical problems appeared to have a positive inﬂu-
ence on the response rate for the online questionnaire
(an increase from 36% to 50%). However, response
rates remained poor despite repeated email prompts,
text messages and phone calls. A third of the interven-
tion group did not see the Men’s Safer Sex website, and
there were no diﬀerences in main outcomes of interest
(condomless sex at 3 months, STI acquisition over
12 months), which was as expected in this small feasi-
bility trial. There was no reported harm from the inter-
vention website or online trial. We discuss the
implications of this feasibility trial for the conduct of
online trials of digital interventions in sexual health
clinic settings.
Technical and practical problems
We encountered technical issues which hampered
recruitment, access to the intervention website and
online data collection at all time points. It was diﬃcult
to set up and maintain access to Wi-Fi for patients in
clinic waiting rooms, since the process for permission
and set-up was complicated, internet connections were
often poor and staﬀ were not always conﬁdent about
remedying internet access problems. Our protocols for
data security demanded passwords with a high level of
security, but these requirements are likely to have made
it harder to remember the passwords.
There were substantial software development errors
that impacted on recruitment of eligible participants,
and upon data collection and access to the intervention
(e.g. errors in links to the outcome questionnaire, login
and password reset functions). Despite careful speciﬁ-
cation of requirements, and manual testing by the
research staﬀ, the extent of these problems were realised
only after patients had been recruited.
The reach and scalability of digital interventions is
potentially excellent, and interest in digital media tech-
nology for health has exploded over the past decade or
Table 2. Demographic characteristics of participants.
Demographic characteristic
Intervention
n¼ 84
Control
n¼ 75
Mean (SD)
Age 29.3 (8.8) 29.5 (8.4)
n (%)
Employment status
School/college/training 10 (11.9) 19 (25.3)
Working 61 (72.6) 49 (65.3)
Unemployed 11 (13.1) 5 (6.7)
Long-term sick or disabled 1 (1.2) 0 (0)
Other 1 (1.2) 2 (2.7)
Ethnicity
White British/Irish/Other 60 (71.4) 50 (66.7)
Black British/Caribbean/
African/Other
11 (13.1) 12 (16.0)
Asian British/Indian/
Pakistani/Bengali
4 (4.8) 4 (5.3)
Chinese/other Asian 2 (2.4) 2 (2.7)
Mixed cultural background 4 (4.8) 4 (5.3)
Other 3 (3.6) 2 (2.7)
Prefer not to say 0 (0) 1 (1.3)
Bailey et al. 7
so, but the NHS lags behind many other institutions in
terms of patient access to digital services.13,17 Reliable
software frameworks for online RCTs are also needed,
which are customisable, user-friendly, and which meet
requirements for secure data protection and data
storage.
Engagement with the MenSS website
Engagement with digital interventions for health pro-
motion can be a major challenge.35 We placed the inter-
vention in clinic waiting rooms to take advantage of the
waiting time that is common in drop-in sexual health
clinics, and this depended upon clinic ﬂow. A third of
the intervention group did not see the MenSS website,
which may have been due to a lack of available time: we
shortened the length of the outcome questionnaire by
capturing only key outcomes at baseline, but research
procedures were still time-consuming (informed con-
sent, online registration, outcome data collection),
especially if participants were aﬀected by the technical
problems described above.
We sent emails at 1-month intervals to prompt men
to access the intervention, and were pleased to ﬁnd that
a third of participants visited the website after their
initial clinic visit, since we had anticipated that the
main window of opportunity for an intervention
would be at the time of the clinic visit. We oﬀered ﬁnan-
cial incentives for follow-up data collection, but not for
engagement with the intervention itself. Eﬀective meth-
ods for engagement need to be established, for example
integrating health promotion websites as a step in a
patient pathway through the clinic.17
Table 3. Condomless sex and STI diagnoses at baseline and follow-up.
Control (n¼ 75) Intervention (n¼ 84)
Outcome
Lower
quartile Median
Upper
quartile Max N
Lower
quartile Median
Lower
quartile Max N
Episodes of condomless vaginal
or anal sex with a woman
(in the past 3 months)
Baseline 2 6 20 50 72 1 4 20 155 72
3 months 3 12 30 100 34 2 10 40 100 23
Number of female sex partners
(without condoms) in the
past 3 months
Baseline 1 1 2 15 72 1 1 2 20 72
3 months 1 1 2 6 34 1 1 2 15 23
Number of male anal sex
partners (without condoms)
in the past 3 months
Baseline 0 0 0 0 72 0 0 0 3 72
3 months 0 0 0 1 34 0 0 1 3 23
STIs (clinic notes)
Baseline 0 0 1 3 69 0 0 1 2 80
12 months 0 0 0 4 69 0 0 0 2 80
Self-reported STI in the last
3 months (online)
Baseline 0 0 0 2 72 0 0 0 1 72
3 months 0 0 0 1 34 0 0 0 1 23
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Table 4. Potential mediators of behaviour change at baseline and follow-up.
Outcome
Control (n¼ 75) Intervention (n¼ 84)
Lower
quartile Median
Upper
quartile Max N
Lower
quartile Median
Upper
quartile Max N
Number of female partners in 3 months
(Baseline) 1 3 4 179 72 1 2 4 55 72
(3 months) 1 2 3 18 34 1 1 4 23 23
Number of male partners in 3 months
(Baseline) 0 0 0 5 72 0 0 0 15 72
(3 months) 0 0 0 0 34 0 0 0 4 23
Episodes of condomless sex due to being
drunk/high in the last 3 months
(Baseline) 0 0 2 20 72 0 0 1 30 72
(3 months) 0 0 3 25 34 0 0 1 5 23
Self-efficacy score
(3 months) 36 40 45 50 33 40 44 46 50 21
Pleasure score
(Baseline) 21 25 29 38 72 19 24 31 41 72
(3 months) 20 24 27 32 34 21 25 30 36 23
Condom problems
(3 months) 1 2 4 8 34 1 2 3 5 23
Motivation
(Baseline) 2 3 4 4 71 2 3 4 4 69
(3 months) 2 3 4 4 32 1 3 3 4 21
Intention
(Baseline) 2 3 3 4 68 2 3 4 4 67
(3 months) 2 3 3 4 32 1 3 3 4 21
Evaluation of condom use
(3 months) 3 4 4 4 34 4 4 4 4 22
Knowledge score
(3 months) 8 9 10 11 34 9 10 11 11 23
Communication score
(3 months) 0 2 4 5 34 1 2 4 5 23
Identity score
(3 months) 25 27 29 35 34 25 28 30 35 23
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STI diagnoses in clinic records
The retrieval rate for data on STI diagnoses collected
from clinic records was 94%, searching by names given,
date attended, email address or telephone number. The
location of data from clinic records could be improved
by requesting additional information from participants
(e.g. date of birth, address, clinic number); however,
soliciting additional identiﬁable data may discourage
some from participating in research. Half of the
sample (72/159) returned to the same clinic within a
year; however, STI diagnoses and service use are
likely to have been underestimated, since participants
are free to attend other sexual health clinics and/or
general practice, and records are not shared between
all clinics. Diﬀerential service use would undermine
the validity of clinically recorded STI diagnosis as an
outcome if patients in diﬀerent experimental arms used
other services at diﬀerent rates. It might be possible to
capture STI diagnoses made at other sites by using
Hospital Episode Statistics and GP practice data.
However, patients in sexual health clinics can choose
pseudonyms, which would make it diﬃcult to link clin-
ical records. Regardless of which services were used,
clinic records are likely to underestimate the cumulative
incidence of STI, particularly if STI are asymptomatic
(and do not trigger a visit to a clinic).
Despite these drawbacks, recording STI diagnoses
from clinical notes has several advantages over self-
reported online outcome measurement: clinic record
data are not subject to recall bias or social desirability
bias, and data collection from records is cheaper in
terms of researcher time and costs of participant
incentives. In addition, ﬁlling in a sexual health ques-
tionnaire may prompt participants to reﬂect on their
behaviour (for both control and intervention partici-
pants),25 potentially reducing the apparent eﬀect of an
intervention. The cumulative incidence of acute STIs
over 1 year was 9.4%, which compares with an
annual recorded rate of 0.85% for new STI diagnoses
for men attending sexual health services in England.36
We were therefore successful in recruiting men at sub-
stantial risk of STI.
Online outcome measurement
Online trials have a number of potential advantages
including automated enrolment, randomisation, data
entry and reminders.17 Online questionnaires can cap-
ture data on a range of outcomes, including sexual well-
being outcomes, which reﬂect participants’
priorities.25,37 However, while online recruitment can
be good, there can be high drop-out rates which sub-
stantially undermine internal validity.17,38 The response
rates for online questionnaires sent by email were poor
(maximally 50%), despite an incentive of £30 for the
ﬁnal questionnaire. We used evidence-based methods to
enhance retention, such as contacting participants mul-
tiple times via diﬀerent routes (by personalised email,
text message and with telephone calls).24,38,39 However,
we do not know whether emails ended up in ‘Junk
Mail’, nor how many participants were put oﬀ by the
initial technical problems with password access and
malfunctioning links to the outcome questionnaire.
The larger incentive (£30) oﬀered at 12 months
appeared to have a positive inﬂuence on the response
Table 5. Group comparisons for condomless sex and STI diagnoses.
Outcome
Baseline Follow-up
IRR
95%
confidence
interval p-value n
Control
Median (n)
Inter-quartile
range
Intervention
Median (n)
Inter-quartile
range
Control
Median (n)
Inter-quartile
range
Intervention
Median (n)
Inter-quartile
range
Number of episodes of condom-
less sex with a woman (in 3
months, at 3-month follow-up)
6 (72)
2,20
4 (72)
1,20
12 (34)
3,30
10 (23)
2,40
1.01 (0.52,1.96) 0.975 55
Number of female partners
(condomless sex) (in 3 months,
at 3-month follow-up)
1 (72)
1,2
1 (72)
1,2
1 (34)
1,2
1 (23)
1,2
1.09 (0.69,1.71) 0.712 55
Number of male partners
(condomless sex) (in 3 months,
at 3-month follow-up)
0 (72)
0,0
0 (72)
0,0
0 (34)
0,0
0 (23)
0,1
1.72 (0.60,4.93) 0.318 55
Number of STI diagnoses from
clinic notes (over 1 year, at
12-month follow-up)
0 (69)
0,1
0 (80)
0,1
0 (69)
0,0
0 (80)
0,0
0.75 (0.29,1.90) 0.543 149
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rate (an increase from 36% to 50%), which is in line
with studies which tested the eﬀect of larger incen-
tives.24,40 However, it is hard to evaluate the eﬀect of
the larger incentive, since the technical problems were
resolved by 12 months, which may have also contribu-
ted to the improved response rate.
Conclusion
Our ﬁndings regarding the conduct of an online RCT of
a website for sexual health for men in a clinic setting
may be applicable more widely. We have shown that
using STI diagnoses from clinical records as a bio-
logical outcome is feasible, but we did not achieve ade-
quate response rates for self-reported online outcomes,
which limits the measurement of sexual wellbeing and
exploration of the mechanism of action of the interven-
tion. Response rates improved with a larger-value vou-
cher (and once technical problems had been remedied).
There are opportunities for exploring the potential
of digital media interventions, and considerable policy
support in the UK, but there are problems to be over-
come before realising their potential in NHS settings,
which include ensuring the reliability of software,
patient access to IT, data security protocols which are
not over-burdensome for patients, minimally time-con-
suming research procedures (e.g. collecting outcome
data at follow-up only) and facilitating patient engage-
ment with digital interventions, for example by inte-
grating digital interventions into routine clinical
pathways.13
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